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CNBr cleavage of unreduced proenzyme Clr yielded fragment CP2b, isolated by gel filtration and high- 
pressure gel permeation chromatography. This fragment (- M, 55ooO) comprised at least 4 disulphide- 
linked peptides, which were separated by gel filtration after reduction and alkylation. Peptide CP2bRA4, 
overlapping the A- and B-chain regions in proenzyme Clr was digested by V8 staphylococcal protease, and 
the digest separated by reversed-phase HPLC. N-terminal sequence analysis of peptide CP2bRA4SP9 estab- 
lished that C lr activation involves the cleavage of a single Arg-Ile bond, located in the sequence: . .. Gln-Arg- 
Gin-Arg-Ile-Ile-Gly-Gly . . . . 
Human Clr Sequence Serine protease activation Limitedproteolysis 
1. INTRODUCTION 
Cl, the first component of the classical pathway 
of complement, comprises a recognition unit, Clq, 
and two zymogens of serine proteases, Clr and 
Cls, which are sequentially activated through 
limited proteolysis during Cl activation [ 1,2]. In 
human, proenzyme Clr is a dimer consisting of 
two apparently identical single-chain glycoproteins 
(-A4* 90000), and during activation each monomer 
undergoes an autocatalytic cleavage generating 
two disulphide-linked polypeptide chains A (Mr 
56000-57000) and B (Mr 30000-35000) [3-51. 
The B chain, which contains the active site serine 
residue, is derived from the C-terminal part of pro- 
enzyme Clr, and its complete sequence has been 
determined [5]. Partial sequence of the N-terminal 
A chain has also recently been obtained, including 
the complete sequence of the C-terminal 95 
residues [6]. Thus, the primary structure of regions 
on both sides of the cleavage site is known, 
although it is not established whether Clr activa- 
tion results from cleavage of a one or more peptide 
bond(s). The isolation from proenzyme Clr of a 
peptide covering the cleavage site, and the se- 
quence of this peptide, allow a definitive answer to 
this question. 
2. MATERIALS AND METHODS 
2.1. Maferials 
Iodo[Z3H]acetic acid (106 mCi/mmol) was 
from the Radiochemical Centre, Amersham. Spec- 
trapor 6 dialysis tubing (Mr cut-off = 1000) was 
purchased from Spectrum Medical Industries. V8 
proteinase from Staphylococcus aureus was from 
Miles Laboratories. Reagents used for HPLC were 
purchased from Merck, and those used for 
automated amino acid sequence analysis were ob- 
tained as described in [7]. 
2.2. Isolation of human proenzyme Clr 
Human Clr was isolated in its proe~yme form 
from outdated plasma by a procedure involving af- 
finity for insoluble IgG-ovalbumin aggregates, as 
described in 141. 
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2.3. CNBr cleavage of proenzyme Clr 
Unreduced proenzyme Clr (200 nmol) was 
dissolved in 70~0 (v/v) formic acid (1.3 ml) con- 
taining CNBr (6.4 mmol) and kept in the dark for 
24 h at 4°C. The mixture was diluted 1: 10 with 
water, freeze-dried, then re-dissolved in 0.1 M 
NH4HC03 (4.5 ml) and applied to a column (2.5 x 
110 cm) of Sephadex G-100, equilibrated with 
0.1 M NHdHC03 and run at a flow rate of 
14 ml/h. Seven pools were collected and freeze- 
dried. Pools 1 and 2 were re-dissolved in 6 M 
urea/O.2 M formic acid (1.0 ml) and submitted to 
high-pressure gel-permeation chromatography on 
a column (7.5 x 600 mm) of TX-G3000 SW 
(LKB) as described previously [8]. In both cases, 
three pools were collected, which were dialysed 
against 0.5% (v/v) acetic acid and freeze-dried. 
2.4. Reduction and u~kylation of CNBr fragment 
CP2b 
Fragment CP2b was dissolved in 6 M 
guanidine-HCY0.4 M Tris-HCl/2 mM EDTA, 
pH 8.0 (3 ml) and reduced with 20 mM 
dithiothreitol, then alkylated by iodof2-3H]acetic 
acid (200 ,&i) as described by Johnson et al. 191. 
After exhaustive dialysis against 0.1 M NHdHC03, 
peptides generated by reduction of fragment CP2b 
were applied to a column (2.5 x 110 cm) of 
Sephadex G-75 equilibrated with 0.1 M NH4HCO3 
and run at a flow rate of 12 ml/h. Six pools were 
collected and freeze-dried. 
2.5. V8 digest of the CNBr peptide overlapping 
the A and B chains 
Peptide CP2bRA4 from pool 4 of Sephadex 
G-75 (33 nmol) was dissolved in 0.1 M 
NH4HC03/2 mM EDTA, pH 7.8 (0.5 ml) and 
digested by V8 staphylococcal protease as de- 
scribed in f5]. The digest was freeze-dried, re- 
dissolved in 0.1% (v/v) tri~uoroacetic acid (1 ml) 
and fractionated by reversed-phase HPLC on a 
yBondapak Cl8 column (3.9 x 300 mm) using sol- 
vent system 2 as described previously [5]. 
2.6, Amino acid anaiys~s and sequence 
deierm~nation 
Amino acid analysis was carried out as in [7]. 
Samples were analysed on a Durrum D-500 or an 
LKB 4400 amino acid analyser. Automated Edman 
degradation was performed on an upgraded 
Beckman 890C sequencer with program number 
345802. Phenylthiohydantoin derivatives were 
identified and quantified by reversed-phase 
HPLC, with an ODS-Hypersil 5~ column (5 x 
100 mm), equilibrated at 1 ml/min with a mixture 
of solution A (0.01 M sodium acetate (pH 
4.2)/methanol, 9: 1, v/v) and solution B 
(acetonitrile/ethanol, 1: 1, v/v) in the ratio 95 : 5 
(v/v), then eluted with a linear gradient (27 min) to 
give a final ratio of 55 : 45 (v/v). 
3. RESULTS 
3.1. rso~ation of the CNBr-cleavage peptide 
overlapping the A and B chain moieties in 
proenzyme Clr 
Unreduced proenzyme Clr was submitted to 
Time (min) 
Fig.1. Isolation of CP2b, the CNBr-cleavage peptide 
ov~riapping the A and B chains regions in proenzyme 
Clr. (A) Initial fractionation of the CNBr digest from 
unreduced proenzyme Clr (200 nmol) by gel filtration 
on Sephadex G-100. (B,C) Further purification of CP2b 
by fractionation of pools 1 (B) and 2 (C) from Sephadex 
G-100 by high-pressure gel permeation on TSK- 
G3OOO SW. 
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CNBr cleavage, and the CNBr-cleavage peptides 
were first fractionated by gem-~ltration on 
Sephadex G-100 (fig.lA). Pools 1 and 2 from 
Sephadex G-100 were further analysed by high- 
pressure gel-permeation on TSK G3000 SW, and 
both resolved in three peaks denoted a,b and c 
(fig.lB,C). Peak lb, originating from pool 1 
(fig.lB) and peak 2b, originating from pool 2 
(fig.lC) both contained a single fragment of ap- 
parent M, approx. 55000 as determined by 
SDS-polyacryl~~de gel el~trophor~is, and were 
pooled together. This fragment, named CP2B, was 
reduced with dithiothreitol and alkylated by 
iodo[2-3H]acetic acid, and the resulting peptides, 
generated by reduction of the disulphide bridges, 
were separated by gel filtration on Sephadex G-75 
(fig.2). 
Amino acid analysis of the pools from Sephadex 
G-75 indicated that pools 1 and 2 contained the 
same peptide, identified as CNBr-cleavage peptide 
CNla from Cir A chain [6], By the same techni- 
que, pools 3 and 5 were found to contain CNBr- 
cleavage peptides CBla from Cir B chain [5,8] and 
CN3 from Cir A chain [6], respectively. Pool 4 
contained a single peptide, CP2bRA4, with an 
amino acid composition (table 1) corresponding to 
the sum of individual amino acid compositions of 
CNZb, the C-terminal CNBr-cleavage peptide 
from the N-terminal A chain of C%r [6], and CB4, 
the N-terminal CNBr-cleavage peptide from the C- 
terminal B chain of Cir [S]. CP2bRA4 was thus 
identified as the CNBr cleavage peptide overlapp- 
ing the A and B chain moieties in proenzyme Clr. 
Table 1 
Amino acid compositions of selected peptides covering the cleavage site of proenzyme Cl? 
Amino 
acid 
CN2bb 
Residues/m01 
CB4’ CN2b + CB4 CP2bRA4 CP2bRA4SPP 
Asx 2.0 ( 2) - ( 2) 2.4 1.1 (1) 
Thr 2.7 ( 3) - ( 3) 2.7 0.4 (0) 
Ser 1.8 ( 2) ( 2) 1.9 - 
HSed - 0.9 (1) ( 1) 0.6 0.7 (1) 
Glx 11.3 (11) 1.1 (1) (12) 12.9 4.4 (4) 
Pro 3.9 ( 4) ( 4) 3.4 3.6 (4) 
Gly 4.7 ( 5) 2.1 (2) ( 7) 7.0 3.1 (3) 
Ala 1.9 ( 2) 1.0 (1) ( 3) 2.5 1.1 (1) 
1% Cyse 3.0 ( 3) - ( 3) 3.0 1.7 (2) 
Val 3.6 ( 4) - ( 4) 3.5 2.7 (3) 
Ilef 1.8 ( 2) 1.5 (2) ( 4) 2.9 2.0 (3) 
Leu 1.0 ( 1) - ( 1) 1.2 0.9 (1) 
Tyr 1.0 ( 1) ( 1) 1.4 0.4 (0) 
Phe - _ 
His _ 
Lys 3.8 ( 4) 1.9 (2) ( 6) 5.5 3.6 (4) 
Arg 4.1 ( 5) - ( 5) 5.0 3.0 (3) 
Trp ( 1) ( 1) 
a Figures in brackets are obtained from sequence 
b Values taken from 161 
’ Values taken from [8] 
d Quantified as the sum of homoserine and homoserine lactone values, except for peptide 
CP2bRA4 (homoserine value) 
e Estimated as S-(carboxymethyI)cysteine 
’ The low value for isoleucine in CB4, CP2bRA4 and CP2bRA4SP9 is due to the presence 
of an Ile-Ile bond partially resistant under standard hydrolysis conditions 
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Fig.2. Separation of the peptides resulting from 
reduction and S-[3H]carboxymethylation of fragment 
CP2b. Fragment CP2b was reduced with dithiothreitol 
and alkylated by iodo~2-3H]acet~c acid as described in 
section 2. Peptides were separated by gel filtration on 
Sephadex G-75. ---, &SO; l , radioactivity of S- 
3.2. Subdigestion of peptide CP2bRA4 and 
sequence of the peptide covering the site 
cleaved during oct~~~tio~ f Clr 
Peptide CP2bRA4 was submitted to subdiges- 
tion by V8 staphylococcal protease, and the digest 
was separated by reversed-phase HPLC (fig.3). 
Eleven pools were collected, containing eight dif- 
ferent peptides identified by amino acid analysis. 
As summarized in fig.4, these peptides resulted 
from expected cleavage of glutamyl bonds at posi- 
I I 
Time (mh) 
Fig.3. Separation by reversed-phase HPLC of peptides 
from subdigest of CP2bRA4 by V8 staphylococca1 
protease. The digest was dissolved in 0.1% (v/v) 
trifluoroacetic acid and separated on yBondapak Cl8 
using solvent system 2 as described previously [S]. 
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Fig.4. Diagrammatic representation of fragments 
generated by subdigestion of peptide CP2bRA4 by V8 
staphylococcal protease. Fragments are numbered 
according to their elution position on HPLC (see fig.3). 
Lack of cleavage of the glutamyl bond at position 46 is 
indicated by a crossed-out arrow. Stippling denotes the 
portion of peptide CP2bRA4SP9 that was sequenced. 
tions 8,10,25 and 29 of CP2bRA4. Cleavage at 
positions 8,10 and 29 was incomplete, whereas the 
Glu-Gln bond at position 46 proved entirely resis- 
tant to enzymatic cleavage. 
Pools 8 and 9 both contained the C-terminal 
peptide from CP2bRA4, CP2bRA4SP9, 
originating from cleavage of the Glu-Lys bond at 
position 29, and overlapping the A and B chain 
moieties in proenzyme Clr (fig.4). Peptide 
CP2bRA4SP9 (7 nmol) was submitted to N- 
terminal sequence analysis, which allowed iden- 
tification of a continuous stretch of 28 amino acid 
residues, corresponding to positions 30-57 of 
CP2bRA4 (fig.4):The sequence data, in agreement 
with amino acid composition of peptide 
CP2bRA4SP9 (table l), indicate unequivocally 
that, in the sequence of proenzyme Clr, the 
arginine residue that is C-terminal in Cir A chain 
forms a peptide bond with the isoleucine residue 
that is N-terminal in Cir B chain. This 
demonstrates that activation of proenzyme Clr 
proceeds through the cleavage of a single Arg-Ile 
bond, in the sequence . . . Gln-Arg-Gln-Arg-Ile-Ile- 
Gly-Gly . . . 
4. DISCUSSION 
Peptide CPZb, resulting from CNBr-cleavage of 
unreduced proenzyme Clr, comprises at least 4 
peptides, which are disulphide-linked. These pep- 
tides originate from both the N-terminal A-chain 
moiety of proenzyme Clr (CNl a and CN3), and 
the C-terminal B-chain moiety (CBla), peptide 
CP2bRA4 overlapping both regions. As peptide 
CBla contains a single half-cystine residue, located 
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at position 114 of Clr B chain [5,8], it can be con- 
eluded that this residue is involved in the single 
d~ulphide bridge that links the A and B chains of 
Clr . This conclusion is in agreement with previous 
observation [5] that half-cystine 114 of CTr B chain 
is homologous to that implicated in the interchain 
disulphide bond in chymotrypsinogen, 
plasminogen, factor X and prothrombin [lo]. 
Gly bonds [6], this protease clearly appears specific 
for arginyl bonds, in agreement with its known 
esterolytic specificity f14f and its ‘trypsin-like’ 
nature, apparent from the amino acid sequence of 
its catalytic B chain [5]. 
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